Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of ESR1 Mutations by Digital PCR During Aromatase Inhibitor Treatment in Metastatic Breast Cancer

NCT02473120 is registered in ClinicalTrials.gov with Centre Henri Becquerel as lead sponsor.

NCT NCT02473120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02473120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of ESR1 Mutations by Digital PCR During Aromatase Inhibitor Treatment in Metastatic Breast Cancer
Lead sponsor
Centre Henri Becquerel
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2015
Completion date
October 31, 2019
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer